Not exactly, but the rebuttal includes:
"As of 2nd March 2020, there are 111 nonsynonymous mutations that have been identified in the outbreak, these have been catalogued here in the CoV-GLUE resource 504 and can be visualised in Figure 1. At current, there is no evidence that any of these 111 mutations have any significance in a functional context of within-host infections or transmission rates."
The premise that there is an "asymptomatic strain" is still theoretically possible but unsubstantiated, despite ongoing investigation.
> "I can’t believe that a month later, this bad science is still being circulated, by a purported PhD and former professor. "
That strikes me as a bit harsh, given that the posted article doesn't actually rely on two-strain to make its case, just the idea of functional variants possibly being out there somewhere. MacLean's rebuttal didn't definitely exclude the possibility that there's some functional variants out there somewhere, we just don't know, haven't seen it in anything we've catalogued so far.
Science is often about calibration. I wouldn't say a search for functional variants is completely worthless. That's why researchers continue to look at variants. On the other hand, completely agree it's overselling to pitch this as a silver bullet for the whole crisis though. Research can be important even when it doesn't solve for everything.